Piperlongumine directly binds TrxR1 in vitro and inactivates TrxR1 in human gastric cancer cells.
Stably overexpressing TrxR1 in SGC-7901 cells markedly rescued piperlongumine-induced growth inhibition
Piperlongumine displays synergistic lethality with GSH inhibitors (BSO and Erastin) against gastric cancer cells.
Piperlongumine treatment markedly reduces the TrxR1 activity and tumor cell burden in vivo.
TrxR1 was significantly overexpressed in gastric cancer cell lines and human gastric cancer tissues.